Cue Biopharma, Inc. Operating Lease, Liability, Noncurrent
Cue Biopharma, Inc. (CUE) had Operating Lease, Liability, Noncurrent of $1.45 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Noncurrent $1.45M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $1.88M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $2.29M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $2.68M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.45M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.88M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.29M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.68M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.10M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $176.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.00M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $1.33M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.96M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.58M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.16M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.85M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $4.60M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $3.16M 10-Q · filed 2024-05-09 | $5.33M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.02M 10-K · filed 2024-03-28 | $6.02M 10-K · filed 2023-03-21 |
| 2022-09-30 | $6.32M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.76M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.76M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $5.12M 10-K · filed 2023-03-21 | |
| 2021-03-31 | $1.08M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.37M 10-K · filed 2022-03-16 | |
| 2020-09-30 | $3.63M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $4.18M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $194.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.35M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $2.61M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.79M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $4.95M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |